The problems and the promise of prostaglandin influences in atherogenesis.
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D003327:Coronary Disease / Q000097:blood / Q000378:metabolism; D011464:Epoprostenol / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000096:biosynthesis* / Q000502:physiology; D011817:Rabbits
D001095:Arachidonic Acids; D005230:Fatty Acids, Nonesterified; D011453:Prostaglandins; D016718:Arachidonic Acid; D011464:Epoprostenol